Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Vertex Pharmaceuticals Inc. sell Canaccord Genuity Group Inc.

Vertex Pharmaceuticals Inc.
Start price
€401.90
24.01.24 / 50%
Target price
€346.79
24.01.25
Performance (%)
11.59%
Price
€448.50
30.08.24
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 11.59%. This prediction currently runs until 24.01.25. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
Vertex Pharmaceuticals Inc. 4.302% 4.302%
iShares Core DAX® 1.560% 2.566%
iShares Nasdaq 100 0.517% 1.894%
iShares Nikkei 225® 1.730% 5.631%
iShares S&P 500 1.482% 1.594%

Comments by Canaccord_Genuity_Gr for this prediction

In the thread Vertex Pharmaceuticals Inc. diskutieren
Prediction Sell
Perf. (%) 11.59%
Target price 346.785
Change
Ends at 24.01.25

Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) was downgraded by analysts at Canaccord Genuity Group Inc. from a "hold" rating to a "sell" rating. They now have a $379.00 price target on the stock, up previously from $332.00.
Ratings data for VRTX provided by MarketBeat

Canaccord Genuity Group Inc. 
0
Report Share
24.01.24